ADAM9 Genetic Variants and Their Role in Modulating Enzyme Activity in Diabetes and Metabolic Traits
A disintegrin and metalloproteinase Domain 9 (ADAM9) is a zinc-dependent proteinase involved in various biological processes. However, its role in the pathophysiology of metabolic syndrome remains unclear, and studies exploring the association between ADAM9 polymorphisms and metabolic traits are lim...
Saved in:
| Main Authors: | Hana Drobiova, Fahd Al-Mulla, Rabeah Al-Temaimi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-01-01
|
| Series: | Journal of Diabetes Research |
| Online Access: | http://dx.doi.org/10.1155/jdr/5519447 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
MMP14 and DDR2 are potential molecular markers for metastatic triple-negative breast cancer
by: Rabeah Al-Temaimi, et al.
Published: (2025-07-01) -
Murine gut microbiota is defined by host genetics and modulates variation of metabolic traits.
by: Autumn M McKnite, et al.
Published: (2012-01-01) -
Benchmarking Variants of the Adam Optimizer for Quantum Machine Learning Applications
by: Tuan Hai Vu, et al.
Published: (2025-01-01) -
ADAM9 expression promotes an aggressive lung adenocarcinoma phenotype
by: Céline Mongaret Kossmann, et al.
Published: (2017-07-01) -
Donor and recipient genetic variants in drug metabolizing enzymes and transporters affect early tacrolimus pharmacokinetics after liver transplantation
by: Alexandra D. Ladd, et al.
Published: (2025-07-01)